These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18381122)

  • 1. Appropriate selection of biochemical targets is one of the most important driver of cost-effectiveness in the discovery of new medicines. Preface.
    Lawton G; Witty DR
    Prog Med Chem; 2008; 46():v-vi. PubMed ID: 18381122
    [No Abstract]   [Full Text] [Related]  

  • 2. The economics of drug development: a grim reality and a role for clinical pharmacology.
    Honig P; Lalonde R
    Clin Pharmacol Ther; 2010 Mar; 87(3):247-51. PubMed ID: 20160740
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness analysis in oncology.
    Meltzer D
    Clin Adv Hematol Oncol; 2010 Sep; 8(9):589-90. PubMed ID: 21157406
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors to consider after cost-benefit analysis.
    Kubica AJ
    Am J Hosp Pharm; 1982 Nov; 39(11):1864, 1869, 1871. PubMed ID: 6816066
    [No Abstract]   [Full Text] [Related]  

  • 5. [A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment].
    Gustafsson LL; Wettermark B; Kalin M; Korkmaz S; Persson ME; Almkvist H; Hjemdahl P; Julander M; Kristianson K; Ringertz B; Bergen-Dahl GT; Wilking N
    Lakartidningen; 2008 Oct 15-21; 105(42):2917-22. PubMed ID: 19025148
    [No Abstract]   [Full Text] [Related]  

  • 6. The value of drug repositioning in the current pharmaceutical market.
    Tobinick EL
    Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bedside-to-bench pharmacology: a complementary concept to translational pharmacology.
    Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 2010 Jun; 87(6):647-9. PubMed ID: 20485323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?
    Patwardhan B; Mashelkar RA
    Drug Discov Today; 2009 Aug; 14(15-16):804-11. PubMed ID: 19477288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where is the hope for drug discovery? Let history tell the future.
    Kong DX; Li XJ; Zhang HY
    Drug Discov Today; 2009 Feb; 14(3-4):115-9. PubMed ID: 18687410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving productivity with model-based drug development: an enterprise perspective.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2010 Aug; 88(2):263-8. PubMed ID: 20592720
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical research and development: what do we get for all that money?
    Light DW; Lexchin JR
    BMJ; 2012 Aug; 345():e4348. PubMed ID: 22872694
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of high cost medicines.
    Jones SW
    N Z Med J; 1994 Mar; 107(974):113. PubMed ID: 8127514
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of high cost medicines.
    Hedley JM
    N Z Med J; 1994 Mar; 107(974):113. PubMed ID: 8127513
    [No Abstract]   [Full Text] [Related]  

  • 15. Kerfuffle!
    Grasela TH; Ludwig E; Fiedler-Kelly J
    J Clin Pharmacol; 2009 Apr; 49(4):386-8. PubMed ID: 19318691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hit finding: towards 'smarter' approaches.
    Langer T; Hoffmann R; Bryant S; Lesur B
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Medicines Company: an emerging pharmaceutical company in cardiology is spearheading an innovative approach to critical care medicines.
    Mayor S
    Eur Heart J; 2009 Jul; 30(13):1541-3. PubMed ID: 19579293
    [No Abstract]   [Full Text] [Related]  

  • 18. New screens and targets in antibacterial drug discovery.
    Falconer SB; Brown ED
    Curr Opin Microbiol; 2009 Oct; 12(5):497-504. PubMed ID: 19651534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational strategies for development of monoclonal antibodies from discovery to the clinic.
    Tabrizi MA; Bornstein GG; Klakamp SL; Drake A; Knight R; Roskos L
    Drug Discov Today; 2009 Mar; 14(5-6):298-305. PubMed ID: 19152840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
    Perakslis ED; Van Dam J; Szalma S
    Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.